摘要
目的探讨普米克令舒联合万托林雾化吸入治疗慢性阻塞性肺疾病(COPD)急性加重期的有效性和安全性。方法 2009年1月～2012年1月我院治疗COPD急性加重期患者66例,患者按入院先后顺序分为观察组34例和对照组32例,比较两组的疗效及治疗前后PaO2、PaCO2的变化情况。结果对照组32例患者的总有效率84.4%;观察组34例患者的总有效率100%;对照组治疗后的疗效明显低于观察组,差异有统计学意义(P<0.05)。观察组治疗后PaO2较对照组显著升高,观察组PaCO2治疗后较对照组显著降低,两组治疗后分别比较,差异有统计学意义(P<0.05)。结论普米克令舒、万托林二者联用雾化吸入治疗慢性阻塞性肺疾病急性加重期疗效确切,安全性好,值得基层医院广泛推广和应用。
Objective To investigate the effect of Pulmicort joint Ventolin inhalation in treatment of acute exacerbation of chronic obstructive pulmonary disease （COPD）. Methods From January 2009 to January 2012, 66 cases of hospital- ized acute exacerbation of COPD patients were selected and randomly divided into observation group of 34 patients, 32 cases of the Control group. Results Of 32 patients in the control group, the total efficiency was 84.4%; Of 34 patients in the treatment group, the total efficiency was 100%; the difference was statistically significant （P 〈 0.05）. PaO2 after treatment of the observation group compared with the control increased significantly, PaCO2 after treatment compared with the control group decreased significantly, the difference was statistically significant （P 〈 0.05）. Conclusion Pulmi- cort joint Ventolin inhalation treatment of COPD patients with acute exacerbation has exact efficacy and good security, it is worth the primary hospital widely promoted and applied.
出处
《中国现代医生》
2013年第6期46-47,共2页
China Modern Doctor
关键词
AECOPD
普米克令舒
万托林
安全性
Acute exacerbation of chronic obstructive pulmonary disease
Pulmicort
Ventolin
Safety
